Palette Life Sciences
Palette Life Sciences is a Swedish medical device company that developed minimally invasive injectable treatments — Barrigel (rectal spacer for radiation therapy), Deflux (pediatric vesicoureteral reflux), and Solesta (fecal incontinence) — serving healthcare providers in gastroenterology, urology, and radiation oncology. Acquired by Teleflex in October 2023.
- Company typePrivate
- Founded2018
- HeadquartersSanta Barbara, United States
- Headcount51–100
- GTM typeB2B
- OfferingHardware or Manufacturing
Palette Life Sciences firmographics
Firmographics- Name
- Palette Life Sciences
- Legal name
- Palette Life Sciences
- Website
- https://palettelifesciences.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Acquired
- Headcount range
- 51–100 employees
- Short description
- Palette Life Sciences is a Swedish medical device company that developed minimally invasive injectable treatments — Barrigel (rectal spacer for radiation therapy), Deflux (pediatric vesicoureteral reflux), and Solesta (fecal incontinence) — serving healthcare providers in gastroenterology, urology, and radiation oncology. Acquired by Teleflex in October 2023.
- Ownership category
- akta.pro rank
Palette Life Sciences industry classification
Industry- Product category
- Medical Devices (Minimally Invasive Gastroenterology and Urology)
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)
- akta.pro primary industry
- Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs) (HLAHANAG)
- akta.pro secondary industry
- Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies) (HSABAKAH)
Keywords
Where Palette Life Sciences is headquartered
LocationHeadquarters
- HQ city
- Santa Barbara
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Palette Life Sciences business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Marketing or Sales, Personnel, Operations
Revenue model
- Medical device and treatment product sales: Revenue generated through the sale of minimally invasive medical treatment products including Barrigel, Deflux, and Solesta for gastroenterology and urology applications. Following acquisition by Teleflex in October 2023, operations are integrated into Teleflex's medical device business.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels1 record
Palette Life Sciences product offering
Product offeringCore offering
Palette Life Sciences develops and markets minimally invasive medical device products for gastrointestinal and urological conditions. Its portfolio includes Barrigel, a hyaluronic acid-based rectal spacer used during radiation therapy; Deflux, an injectable treatment for pediatric vesicoureteral reflux; and Solesta, an injectable therapy for fecal incontinence. Following its October 2023 acquisition by Teleflex, the products continue to be sold under their respective brand names through Teleflex's medical device infrastructure.
Differentiator
Problem solved
Functional benefit
Brands
- Barrigel: A flagship minimally invasive treatment product.
- Deflux
- Solesta
Products and services
- Barrigel
Companies that use Palette Life Sciences
Customer profileSegments1 record
Ideal customer profiles1 record
Palette Life Sciences technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Palette Life Sciences partnerships and signals
Strategic signalScale indicators3 records
Palette Life Sciences competitors and assessment
Company assessmentDirect peers
- Coloplast: Danish medical device company with a leading continence care and ostomy portfolio directly comparable to Palette's Solesta fecal incontinence franchise and adjacent to its urology offerings. Competes in the same specialist customer base and minimally invasive treatment category.
- Cook Medical: U.S. privately-held medical device manufacturer with deep gastroenterology and urology portfolios, directly comparable to Palette's GI/urology focus. Competes for the same specialist physician customers across minimally invasive procedural categories.
- Merit Medical Systems: Medical device company with meaningful gastroenterology and urology product lines, including devices used in interventional procedures directly comparable to Palette's minimally invasive treatment approach.
- Laborie Medical Technologies: Specialty medical technology company focused on urology and pelvic health, directly comparable to Palette's Deflux pediatric urology franchise. Competes for the same specialist urology customer base.
- Hollister Incorporated: Private medical products company with continence care and ostomy portfolios directly comparable to Palette's Solesta franchise. Competes for the same incontinence specialist and patient channels.
- Wellspect Healthcare: Mölnlycke-owned urology and continence care company directly competing in the same specialist categories as Palette's Deflux and Solesta franchises.
Broad incumbents
- Olympus Corporation: Global leader in gastroenterology endoscopy and related minimally invasive devices. A broad incumbent whose GI franchise overlaps with Barrigel-adjacent clinical workflows and competes for the same gastroenterology specialist customers.
- Boston Scientific: Large diversified medical device company with material gastroenterology and urology franchises. Operates broadly across minimally invasive procedural categories overlapping with Palette's specialty focus.
- Conmed Corporation: Medical device company with gastroenterology and general surgery product lines overlapping with Palette's minimally invasive procedural focus. Broad incumbent competing for similar hospital budgets.
Others
- Teleflex Incorporated: Parent company following the October 2023 acquisition. Functions as both owner and adjacent competitor, with its own urology and interventional medical device franchises that may overlap with Palette's portfolio at the corporate level.
Market position
Customer concentration
Palette Life Sciences social profiles
Digital presencePalette Life Sciences financial estimates
Financial estimateRevenue estimate
Valuation estimate
Palette Life Sciences leadership team
Management profileNumber of profiles
Profiles6 records
Palette Life Sciences funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Palette Life Sciences M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Palette Life Sciences
What does Palette Life Sciences do?
Palette Life Sciences develops and markets minimally invasive medical device products for gastrointestinal and urological conditions. Its portfolio includes Barrigel, a hyaluronic acid-based rectal spacer used during radiation therapy; Deflux, an injectable treatment for pediatric vesicoureteral reflux; and Solesta, an injectable therapy for fecal incontinence. Following its October 2023 acquisition by Teleflex, the products continue to be sold under their respective brand names through Teleflex's medical device infrastructure.
Is Palette Life Sciences a public or private company?
Palette Life Sciences is a private company. It is classified as corporate owned and is currently acquired.
When was Palette Life Sciences founded?
Palette Life Sciences was founded in 2018. It employs 51 to 100 people.
Where is Palette Life Sciences based?
Palette Life Sciences is headquartered in Santa Barbara, United States, in the North America region.
How does Palette Life Sciences make money?
One revenue line is on record: medical device and treatment product sales.
Who are Palette Life Sciences's main competitors?
Direct peers on record are Coloplast, Cook Medical, Merit Medical Systems, Laborie Medical Technologies, Hollister Incorporated and Wellspect Healthcare. Broad incumbents are Olympus Corporation, Boston Scientific and Conmed Corporation. Teleflex Incorporated is listed as an others.
Does Palette Life Sciences have an API?
No public API is recorded for Palette Life Sciences.
What industry is Palette Life Sciences in?
Palette Life Sciences's product category is Medical Devices (Minimally Invasive Gastroenterology and Urology). Its primary akta.pro industry code is HLAHANAG, Single-Use Medical Disposables & Procedure Kits (Drapes, Tubing, Catheters, Syringes, Custom Packs), with a secondary code of HSABAKAH, Incontinence & Urological Supplies (Catheters, Briefs, Ostomy Supplies). Its NAICS code is 339113 and its SIC code is 3841.